ArticleBlood2019
Resolution of sickle cell disease-associated inflammation and tissue damage with 17
Open access · bronzeAbstract read
In one paragraph
Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 65 citations in OpenAlex.
- Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria.Blood advances · 2023Trial
- Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention.EBioMedicine · 2023Trial
- Colchicine Protects Against Sickle Cell Related Cardiomyopathy: Evidence of the Novel Role of Inflammaging.Antioxidants (Basel, Switzerland) · 2026Article
- Splenic erythrophagocytosis is regulated by ALX/FPR2 signaling.Haematologica · 2026Article
- Nouveau benzo-mimetics of 17R-Resolvin D2 are potent resolution agonists for inflammation.iScience · 2025Article
- Article
- Plasma oxylipins in children with sickle cell disease: Associations with biomarkers of inflammation and endothelial activation.Prostaglandins, leukotrienes, and essential fatty acids · 2025Article
- Mitapivat metabolically reprograms human β-thalassemic erythroblasts, increasing their responsiveness to oxidation.Blood advances · 2025Article
- 17(R)-Resolvin D1 protects against sickle cell-related inflammatory cardiomyopathy in humanized mice.Blood · 2025Article
- The Role of Resolvin D1 in the Differential Diagnosis of Pancreatic Ductal Adenocarcinoma and Acute Pancreatitis: A Case-Control Study.Medicina (Kaunas, Lithuania) · 2025Article
- Specialized pro-resolving mediators in neutrophil apoptosis regulation: unlocking novel therapeutic potential in kidney diseases.Frontiers in immunology · 2025Review
- Review
- The effects of compound probiotics on production performance, rumen fermentation and microbiota ofFrontiers in veterinary science · 2024Article
- Nephrological Complications in Hemoglobinopathies: SITE Good Practice.Journal of clinical medicine · 2023Article
- Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis.JCI insight · 2023Article
- Crosstalk between the plasminogen/plasmin system and inflammation resolution.Journal of thrombosis and haemostasis : JTH · 2023Review
- Stereochemistry and functions of the new cysteinyl-resolvin, 4S,5R-RCTR1, in efferocytosis and erythrophagocytosis of human senescent erythrocytes.American journal of hematology · 2023Article
- Duality of Nrf2 in iron-overload cardiomyopathy.Haematologica · 2023Article
- Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach.Journal of clinical medicine · 2023Review
- Targeting Angiogenesis via Resolution of Inflammation.Cold Spring Harbor perspectives in medicine · 2023Review
Corrections and comments
- Commented on by
Authors and funding
18 authors at 7 institutions in 3 countries.
Alessandro MatteDepartment of Medicine, University of Verona, Policlinico GB Rossi-Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Antonio RecchiutiDepartment of Medical, Oral, and Biotechnology Science and Center of Excellence on Aging and Translational Medicine, "G. d'Annunzio" University of Chieti, Chieti, Italy.ORCID 0000-0002-1409-5261
Enrica FedertiDepartment of Medicine, University of Verona, Policlinico GB Rossi-Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Bérengère KoehlLaboratoire d'Excellence GR-Ex, Unité Biologie Intégrée du Globule Rouge, NTS, INSERM, Paris Diderot University, Sorbonne Paris Cité University, Paris, France.
Thomas MintzParis Cardiovascular Research Centre, INSERM and Paris Descartes University, Paris, France.
Wassim El NemerLaboratoire d'Excellence GR-Ex, Unité Biologie Intégrée du Globule Rouge, NTS, INSERM, Paris Diderot University, Sorbonne Paris Cité University, Paris, France.
Pierre-Louis TharauxParis Cardiovascular Research Centre, INSERM and Paris Descartes University, Paris, France.ORCID 0000-0002-6062-5905
Valentine BrousseAssistance Publique Hopitaux de Paris, Necker Hospital, Paris, France.
Immacolata AndolfoDepartment of Molecular Medicine and Medical Biotechnologies, Federico II University, and CEINGE, Biotecnologie Avanzate, Naples, Italy.ORCID 0000-0003-0493-812X
Alessia LamolinaraCenter of Excellence on Aging and Translational Medicine, Department of Medicine and Aging Science, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Olga WeinbergDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA.
Angela SicilianoDepartment of Medicine, University of Verona, Policlinico GB Rossi-Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Paul C NorrisCenter of Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and.ORCID 0000-0003-2512-0829
Ian R RileyCenter of Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and.
Achille IolasconDepartment of Molecular Medicine and Medical Biotechnologies, Federico II University, and CEINGE, Biotecnologie Avanzate, Naples, Italy.ORCID 0000-0002-9558-0356
Charles N SerhanCenter of Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and.ORCID 0000-0003-4627-8545
Carlo BrugnaraDepartment of Laboratory Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA.
Lucia De FranceschiDepartment of Medicine, University of Verona, Policlinico GB Rossi-Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.ORCID 0000-0001-7093-777X
Inserm · FRUniversity of Verona · ITBrigham and Women's Hospital · USBoston Children's Hospital · USCeinge Biotecnologie Avanzate (Italy) · ITUniversity of Chieti-Pescara · ITAssistance Publique – Hôpitaux de Paris · FR
Funding
BLOOD CELL LIPOXYGENASE PRODUCTS: FORMATION AND ACTIONR01GM038765 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 1992 to 2020
$4.9MNIGMS NIH HHS R01 GM038765
Abstract
Resolvins (Rvs), endogenous lipid mediators, play a key role in the resolution of inflammation. Sickle cell disease (SCD), a genetic disorder of hemoglobin, is characterized by inflammatory and vaso-occlusive pathologies. We document altered proresolving events following hypoxia/reperfusion in humanized SCD mice. We demonstrate novel protective actions of 17
Indexed as
Anemia, Sickle CellAnimalsAnti-Inflammatory Agents, Non-SteroidalCytokinesDocosahexaenoic AcidsHumansKidney DiseasesMiceNeutrophilsPneumoniaAnti-Inflammatory Agents, Non-SteroidalCytokinesDocosahexaenoic Acidsresolvin D1
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.